American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Range Resources (NYSE:RRC) PT Raised to $33.00

Range Resources (NYSE:RRC) PT Raised to $33.00

Range Resources (NYSE:RRC – Get Free Report) had its price objective boosted by equities research analysts at Morgan Stanley from $23.00 to $33.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage... More of this article »
Image about Truist Financial Increases Amazon.com (NASDAQ:AMZN) Price Target to $216.00

Truist Financial Increases Amazon.com (NASDAQ:AMZN) Price Target to $216.00

Amazon.com (NASDAQ:AMZN) had its price objective lifted by stock analysts at Truist Financial from $195.00 to $216.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. The brokerage presently has a “buy”... More of this article »
Image about GE Vernova (NYSE:GEV) Coverage Initiated at BNP Paribas

GE Vernova (NYSE:GEV) Coverage Initiated at BNP Paribas

Investment analysts at BNP Paribas started coverage on shares of GE Vernova (NYSE:GEV – Get Free Report) in a research note issued on Wednesday, Marketbeat Ratings reports. The firm set an “outperform” rating and... More of this article »
Image about Barclays Increases Broadcom (NASDAQ:AVGO) Price Target to $1,500.00

Barclays Increases Broadcom (NASDAQ:AVGO) Price Target to $1,500.00

Broadcom (NASDAQ:AVGO – Get Free Report) had its price objective raised by Barclays from $1,405.00 to $1,500.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. The brokerage presently has an “overweight”... More of this article »
Image about bioAffinity Technologies (BIAF) & Its Rivals Financial Comparison

bioAffinity Technologies (BIAF) & Its Rivals Financial Comparison

bioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 38 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its rivals? We will compare bioAffinity Technologies... More of this article »
Image about Q3 2024 EPS Estimates for JPMorgan Chase & Co. (NYSE:JPM) Reduced by Analyst

Q3 2024 EPS Estimates for JPMorgan Chase & Co. (NYSE:JPM) Reduced by Analyst

JPMorgan Chase & Co. (NYSE:JPM – Free Report) – Equities researchers at Seaport Res Ptn dropped their Q3 2024 EPS estimates for JPMorgan Chase & Co. in a note issued to investors on Monday, April 15th. Seaport... More of this article »
Image about Research Analysts’ Weekly Ratings Changes for QUALCOMM (QCOM)

Research Analysts’ Weekly Ratings Changes for QUALCOMM (QCOM)

Several brokerages have updated their recommendations and price targets on shares of QUALCOMM (NASDAQ: QCOM) in the last few weeks: 4/16/2024 – QUALCOMM is now covered by analysts at Evercore ISI. They set an “in-line”... More of this article »
Image about FY2024 EPS Estimates for Wesdome Gold Mines Ltd. Increased by Echelon Wealth Partners (TSE:WDO)

FY2024 EPS Estimates for Wesdome Gold Mines Ltd. Increased by Echelon Wealth Partners (TSE:WDO)

Wesdome Gold Mines Ltd. (TSE:WDO – Free Report) – Echelon Wealth Partners upped their FY2024 earnings estimates for Wesdome Gold Mines in a note issued to investors on Tuesday, April 16th. Echelon Wealth Partners analyst... More of this article »
Image about Q3 2024 Earnings Estimate for JAKKS Pacific, Inc. Issued By Zacks Research (NASDAQ:JAKK)

Q3 2024 Earnings Estimate for JAKKS Pacific, Inc. Issued By Zacks Research (NASDAQ:JAKK)

JAKKS Pacific, Inc. (NASDAQ:JAKK – Free Report) – Equities research analysts at Zacks Research increased their Q3 2024 EPS estimates for JAKKS Pacific in a research report issued on Tuesday, April 16th. Zacks Research... More of this article »
Image about Syros Pharmaceuticals (SYRS) – Analysts’ Weekly Ratings Changes

Syros Pharmaceuticals (SYRS) – Analysts’ Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Syros Pharmaceuticals (NASDAQ: SYRS) in the last few weeks: 4/17/2024 – Syros Pharmaceuticals was downgraded by analysts at StockNews.com... More of this article »
Image about Seaport Res Ptn Research Analysts Lower Earnings Estimates for The Bank of New York Mellon Co. (NYSE:BK)

Seaport Res Ptn Research Analysts Lower Earnings Estimates for The Bank of New York Mellon Co. (NYSE:BK)

The Bank of New York Mellon Co. (NYSE:BK – Free Report) – Research analysts at Seaport Res Ptn dropped their Q3 2024 earnings per share estimates for shares of Bank of New York Mellon in a research note issued to investors... More of this article »
Image about FY2024 Earnings Estimate for Starbucks Co. (NASDAQ:SBUX) Issued By William Blair

FY2024 Earnings Estimate for Starbucks Co. (NASDAQ:SBUX) Issued By William Blair

Starbucks Co. (NASDAQ:SBUX – Free Report) – William Blair decreased their FY2024 earnings per share (EPS) estimates for shares of Starbucks in a research note issued to investors on Tuesday, April 16th. William Blair... More of this article »
Image about Equities Analysts Issue Forecasts for Unity Biotechnology, Inc.’s FY2024 Earnings (NASDAQ:UBX)

Equities Analysts Issue Forecasts for Unity Biotechnology, Inc.’s FY2024 Earnings (NASDAQ:UBX)

Unity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – HC Wainwright raised their FY2024 earnings per share (EPS) estimates for Unity Biotechnology in a research note issued to investors on Tuesday, April 16th. HC Wainwright... More of this article »
Image about M&T Bank Co. (NYSE:MTB) to Post FY2024 Earnings of $14.12 Per Share, Wedbush Forecasts

M&T Bank Co. (NYSE:MTB) to Post FY2024 Earnings of $14.12 Per Share, Wedbush Forecasts

M&T Bank Co. (NYSE:MTB – Free Report) – Equities research analysts at Wedbush decreased their FY2024 EPS estimates for shares of M&T Bank in a research note issued on Monday, April 15th. Wedbush analyst D.... More of this article »
Image about Q3 2024 Earnings Forecast for Biogen Inc. Issued By Wedbush (NASDAQ:BIIB)

Q3 2024 Earnings Forecast for Biogen Inc. Issued By Wedbush (NASDAQ:BIIB)

Biogen Inc. (NASDAQ:BIIB – Free Report) – Research analysts at Wedbush raised their Q3 2024 EPS estimates for shares of Biogen in a research report issued to clients and investors on Wednesday, April 17th. Wedbush analyst... More of this article »